A Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Overweight/Obese Subjects of Japanese or Chinese Descent

Trial Identifier: D5670C00012
Sponsor: MedImmune, LLC
NCTID:: NCT03385369
Start Date: January 2018
Primary Completion Date: April 2018
Study Completion Date: April 2018
Condition: Healthy Volunteers; Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
Chinese Translation
Japanese Translation

Trial Locations

Country Location
United States of America, CA Anaheim, CA, United States of America, 92801